Research Article

Hybrid Disease Diagnosis Using Multiobjective Optimization with Evolutionary Parameter Optimization

Table 4

Signed-rank test at LOS 0.05 on resampled data.

DatasetObjectivesPSVMGSVMFSVMPMLPGMLP
valueH valueH valueH valueH valueH

ClevelandPAC3.69E−0513.69E−0513.69E−0518.75E−518.125E−51
SEN4.4E−0512.98E−0513.69E−0516.875E−511.542E−41
SPE3.69E−0514.4E−0514.4E−0518.125E−514.3751

StatlogPAC3.69E−0512.98E−0513.69E−0516.11E−0512.31E−051
SEN3.69E−0513.69E−0514.4E−0513.69E−0514.4E−051
SPE2.98E−0514.4E−0513.69E−0514.4E−0514.4E−051

SpectPAC4.4E−0514.4E−0514.4E−0510.00096315E−051
SEN4.4E−0517.23E−0514.4E−0510.00753310.0091411
SPE2.98E−0513.69E−0513.69E−0512.98E−0513.69E−051

SpectfPAC2.98E−0514.4E−0513.69E−0515.17E−0510.0007261
SEN4.4E−0514.4E−0518.51E−0510.00062910.000821
SPE4.4E−0514.4E−0513.69E−0512.98E−0510.0006271

EricPAC4.4E−0514.4E−0514.4E−0518.75E−513.69E−051
SEN4.4E−0514.4E−0514.4E−0515.2E−0513.69E−051
SPE3.69E−0512.98E−0512.98E−0513.69E−0513.69E−051

WBCPAC4.37E−0513.55E−0514.37E−0511.3982E−515.38E−051
SEN4.4E−0513.69E−0514.4E−0515.625E−510.61270
SPE4.4E−0514.4E−0514.4E−0514.235E−516.11E−051

HepatitisPAC4.4E−0513.69E−0513.69E−0514.375E−518.475E−51
SEN4.37E−0515.2E−0513.69E−0510.875E−511.873E−51
SPE4.4E−0513.69E−0513.69E−0511.321E−511.098E−51

ThyroidPAC4.4E−0513.69E−0513.69E−0514.4E−0514.4E−051
SEN4.4E−0514.4E−0512.98E−0514.4E−0512.98E−051
SPE4.4E−0513.69E−0514.4E−0510.02657710.0075331

ParkinsonPAC4.4E−0514.4E−0513.69E−0513.69E−0514.37E−051
SEN4.4E−0512.98E−0514.4E−0510.00685510.0323661
SPE4.4E−0514.4E−0513.69E−0512.98E−0513.69E−051

Pima Indian diabeticsPAC4.4E−0514.4E−0514.4E−0513.69E−0511E−041
SEN3.69E−0513.69E−0512.98E−0513.69E−0512.98E−051
SPE4.4E−0514.4E−0513.69E−0513.69E−0513.69E−051

BUPA liver diseasePAC4.4E−0513.69E−0514.4E−0514.4E−0513.69E−051
SEN4.4E−0513.69E−0514.4E−0514.4E−0514.4E−051
SPE3.69E−0513.69E−0513.69E−0512.31E−0512.31E−051